As of 2026-09-08, the Relative Valuation of Abbott Laboratories (ABT) is 116.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 108.33 USD, the upside of Abbott Laboratories based on Relative Valuation is 7.2%.
The range of the Relative Valuation is 102.90 - 136.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.8x - 35.4x | 34.2x |
| Forward P/E multiples | 24.7x - 29.4x | 26.9x |
| Fair Price | 102.90 - 136.36 | 116.16 |
| Upside | -5.0% - 25.9% | 7.2% |
| Date | P/E |
| 2026-09-04 | 34.55 |
| 2026-09-03 | 34.70 |
| 2026-09-02 | 35.24 |
| 2026-09-01 | 34.74 |
| 2026-08-31 | 35.20 |
| 2026-08-28 | 35.87 |
| 2026-08-27 | 35.59 |
| 2026-08-26 | 36.39 |
| 2026-08-25 | 37.04 |
| 2026-08-24 | 37.21 |
| 2026-08-21 | 37.20 |
| 2026-08-20 | 36.41 |
| 2026-08-19 | 36.50 |
| 2026-08-18 | 35.94 |
| 2026-08-17 | 35.20 |
| 2026-08-14 | 35.48 |
| 2026-08-13 | 35.49 |
| 2026-08-12 | 35.38 |
| 2026-08-11 | 35.00 |
| 2026-08-10 | 34.65 |
| 2026-08-07 | 34.39 |
| 2026-08-06 | 34.44 |
| 2026-08-05 | 33.72 |
| 2026-08-04 | 33.64 |
| 2026-08-03 | 34.17 |
| 2026-07-31 | 33.71 |
| 2026-07-30 | 33.69 |
| 2026-07-29 | 34.45 |
| 2026-07-28 | 34.22 |
| 2026-07-27 | 33.33 |
| 2026-07-24 | 32.87 |
| 2026-07-23 | 32.14 |
| 2026-07-22 | 32.08 |
| 2026-07-21 | 31.79 |
| 2026-07-20 | 32.43 |
| 2026-07-17 | 32.11 |
| 2026-07-16 | 31.52 |
| 2026-07-15 | 28.47 |
| 2026-07-14 | 28.38 |
| 2026-07-13 | 29.38 |
| 2026-07-10 | 29.96 |
| 2026-07-09 | 30.11 |
| 2026-07-08 | 30.36 |
| 2026-07-07 | 30.57 |
| 2026-07-06 | 30.50 |
| 2026-07-02 | 30.43 |
| 2026-07-01 | 29.40 |
| 2026-06-30 | 28.94 |
| 2026-06-29 | 29.57 |
| 2026-06-26 | 30.02 |